Cited by 114Malaria Research and ControlBiosensors and Analytical DetectionVector-borne infectious diseases

Persistent ICT Malaria P.f/P.v Panmalarial and HRP2 Antigen Reactivity after Treatment of Plasmodium falciparum Malaria Is Associated with Gametocytemia and Results in False-Positive Diagnoses of Plasmodium vivax in Convalescence

Open access
Tjitra, Emiliana, Suprianto, Sri, McBroom, James, Currie, Bart J., Anstey, Nicholas M.·2001·Journal of Clinical Microbiology

Abstract

A problem with rapid Plasmodium falciparum -specific antigen histidine-rich protein 2 (HRP2) detection tests for malaria is the persistence of antigen in blood after the disappearance of asexual-stage parasitemia and clinical symptoms, resulting in false-positive (FP) test results following treatment. The ICT P.f/P.v immunochromatographic test detects both HRP2 and a panmalarial antigen (PMA) found in both P. falciparum and Plasmodium vivax . To examine posttreatment antigen persistence with this test and whether persistent sexual-stage forms (gametocytes) are a cause of FP tests after treatment, we compared serial antigen test results with microscopy results from patients symptomatic with P. falciparum malaria in Indonesia for 28 days following treatment with chloroquine (CQ; n = 66), sulfadoxine-pyrimethamine (SP; n = 36), and artesunate plus sulfadoxine-pyrimethamine (ART + SP; n = 15). Persistent FP antigenemia following SP treatment occurred in 29% (HRP2) and 42% (PMA) of the patients on day 7 and in 10% (HRP2) and 23% (PMA) on day 14. The high rates of persistent HRP2 and PMA antigenemia following CQ and SP treatment were strongly associated with the presence of gametocytemia, with the proportion with gametocytes on day 7 posttreatment being significantly greater in those with FP results than in those with true-negative PMA and HRP2 results. Gametocyte frequency on day 14 post-SP treatment was also greater in those with FP PMA results. Following SP treatment, PMA persisted longer than HRP2, giving an FP diagnosis of P. vivax in up to 16% of patients on day 14, with all FP P. vivax diagnoses having gametocytemia. In contrast, PMA was rapidly cleared following ART + SP treatment in association with rapid clearance of gametocytemia. Gametocytes appear to be an important cause of persistent posttreatment panmalarial antigenemia in areas of endemicity and may also contribute in part to persistent HRP2 antigenemia following treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jcm.39.3.1025-1031.2001

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An important weakness of RDT-HRP2 tests is the prolonged half-life of HRP-2 antigen, which can be identified in plasma several weeks after parasite clearance and therefore cannot distinguish current from recent infection.

    “An important weakness of RDT-HRP2 tests is the prolonged half-life of the antigen. HRP-2 can be identified in plasma samples several weeks after parasite clearance, and therefore cannot be used to distinguish current from recent infection [23–25].”

    From Diagnosing malaria in pregnancy: An update (2012) · cites this paper as [24]

  • These shortcomings hinder the use of existing RDTs for managing malaria and for monitoring treatment efficacy.

    “These shortcomings hinder the use of existing RDT for managing malaria, and also for monitoring treatment efficacy [23–25].”

    From Diagnosing malaria in pregnancy: An update (2012) · cites this paper as [24]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. In H. Gilles and D. Warrell (ed.), Essential malariology, 3rd ed. Edward Arnold, London, United Kingdom.

Cited by

Sorted by citations

Authors
Tjitra, E., Suprianto, S., McBroom, J., Currie, B. J., & Anstey, N. M.
Affiliations
  • Menzies School of Health Research (AU)
  • <!--label omitted: 3-->Directorate General of Communicable Disease Control and Environmental Health,3 Jakarta, Indonesia, and
Venue
Journal of Clinical Microbiology
Published
2001-03
Volume
39
Issue
3
Pages
1025-1031
ISSN
  • 0095-1137 (ISSN-L)
  • 1098-660X
OpenAlex
W1997483009
Cited by
113
References
22
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 7 · 2021: 5 · 2020: 1 · 2019: 6 · 2018: 5 · 2017: 6 · 2015: 5 · 2014: 5 · 2013: 11 · 2012: 9
FWCI
3.49
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Microbiology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • CDU eSpace Institutional Repository (Charles Darwin University) (submittedVersion)
  • Griffith Research Online (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
  • Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
Keywords
falciparum malaria, Plasmodium vivax, HRP2 antigen, false-positive diagnosis, gametocytaemia, rapid diagnostic tests, sulfadoxine-pyrimethamine, chloroquine, convalescence
MeSH terms
Adult, Animals, Antigens, Protozoan, Antimalarials, Child, Child, Preschool, Convalescence, False Positive Reactions, Humans, Immunologic Tests, Microscopy, Plasmodium falciparum, Plasmodium vivax, Malaria, Falciparum, Malaria, Vivax

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review